HM Centro Integral Oncologico Clara Campal

Madrid, Other 28050

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Cervical Cancer, Classical Hodgkin Lymphoma, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma, Fallopian Tube Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma, Head and Neck Squamous Cell Carcinoma, Non-small Cell Lung Cancer, Ovarian Cancer, Peripheral T-cell Lymphoma

Studies at this site

• Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer — Stopped early
• A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) — Completed